ICE vs STRO
Intercontinental Exchange Inc (ICE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ICE and STRO stock pages for the full models.
Not investment advice.